Autonomous Cortisol Secretion Influences Psychopathological Symptoms in Patients With Primary Aldosteronism
- 17 February 2021
- journal article
- research article
- Published by The Endocrine Society in Journal of Clinical Endocrinology & Metabolism
- Vol. 106 (6), e2423-e2433
- https://doi.org/10.1210/clinem/dgab099
Abstract
Context Primary aldosteronism (PA) is associated with impaired quality of life (QoL). Autonomous cortisol co-secretion (ACS) is a relevant phenotype of PA, which could contribute to depression and anxiety disorders. This has not been investigated so far. Objective To evaluate the prevalence of depression and anxiety in PA patients according to ACS. Methods We performed testing for hypercortisolism and evaluated anxiety, depression and QoL by self-rating questionnaires in newly diagnosed PA patients of the German Conn´s Registry; 298 patients were reevaluated at follow-up. Results In the overall cohort, scores for anxiety (p<0.001), depression (p<0.001), and QoL (mental p=0.021; physical p=0.015) improved significantly at follow-up. This improvement was seen in both subgroups of patients with and without ACS, with the exception of the mental subscore in no-ACS patients. Analysis for sex differences showed that anxiety decreased significantly in females with ACS and no-ACS, whereas males with no-ACS failed to improve. Depression improved significantly in males and females with ACS (p=0.004, p=0.011 respectively), but not in those with no-ACS. Physical subscore of QoL improved significantly (p=0.023) in females with ACS and mental subscore (p=0.027) in males with ACS, whereas no differences were seen for the no-ACS groups. Conclusion Improvement in depression and anxiety scores in response to treatment of PA is more pronounced in patients with ACS in contrast to no-ACS suggesting a role of ACS in the psychopathological symptoms of patients with PA. Furthermore, we observed significant differences in depression and anxiety scores between the sexes.Keywords
Funding Information
- Else Kröner-Fresenius Stiftung
- German Conn’s Registry-Else-Kröner Hyperaldosteronism Registry (2013_A182, 2015_A171, 2019_A104)
- European Research Council
- European Union’s Horizon 2020 (694913)
- Deutsche Forschungsgemeinschaft
This publication has 53 references indexed in Scilit:
- Prevalence of Primary Aldosteronism in Patient's Cohorts and in Population-based Studies - A Review of the Current LiteratureHormone and Metabolic Research, 2011
- Aldosterone- and cortisol-co-secreting adrenal tumors: the lost subtype of primary aldosteronismActa Endocrinologica, 2011
- Chronic treatment with the mineralocorticoid hormone aldosterone results in increased anxiety-like behaviorHormones and Behavior, 2008
- The Diagnosis of Cushing's Syndrome: An Endocrine Society Clinical Practice GuidelineJournal of Clinical Endocrinology & Metabolism, 2008
- Psychological Aspects of Primary AldosteronismPsychotherapy and Psychosomatics, 2006
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of Internal Medicine, 2006
- Conn’s Syndrome Presenting as DepressionAmerican Journal of Psychiatry, 2005
- The Corticosteroid Receptor Hypothesis of DepressionNeuropsychopharmacology, 2000
- Cross-Validation of Item Selection and Scoring for the SF-12 Health Survey in Nine Countries: Results from the IQOLA ProjectJournal of Clinical Epidemiology, 1998
- A 12-Item Short-Form Health SurveyMedical Care, 1996